Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
930,177
-
Share change
-
-234,617
-
Total reported value
-
$5,393,000
-
Price per share
-
$5.80
-
Number of holders
-
16
-
Value change
-
-$2,053,190
-
Number of buys
-
9
-
Number of sells
-
6
Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS (GLMD) as of Q4 2014
As of 31 Dec 2014,
GALMED PHARMACEUTICALS LTD - SHS (GLMD) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
930,177 shares.
The largest 10 holders included
683 Capital Management, LLC, Park West Asset Management LLC, DAFNA Capital Management LLC, PERCEPTIVE ADVISORS LLC, Knoll Capital Management, LP, GOLDMAN SACHS GROUP INC, GRT CAPITAL PARTNERS LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, and Spark Investment Management LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.